Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Bafna Pharmaceuticals Ltd banner

Bafna Pharmaceuticals Ltd
NSE:BAFNAPH

Watchlist Manager
Bafna Pharmaceuticals Ltd Logo
Bafna Pharmaceuticals Ltd
NSE:BAFNAPH
Watchlist
Price: 112.5 INR -3.18% Market Closed
Market Cap: ₹2.7B
Write Note Create Alert Ask AI

Bafna Pharmaceuticals Ltd
Investor Relations

Bafna Pharmaceuticals Ltd. engages in the manufacture of drugs and medicines of life saving drugs. The company is headquartered in Chennai, Tamil Nadu. The company went IPO on 2008-06-27. The firm is manufacturing over 336 licensed pharmaceutical formulations and has globally registered approximately 78 of its products. The firm caters to both domestic and international markets. The firm has two manufacturing facilities in Chennai. Its Madhavram facility manufactures finished solid oral and liquid oral dosage forms of Betalactam and Non-Betalactam and Cephalosporin products. The firm supplies its finished products to countries including Sri Lanka, Ghana, Ukraine, and Laos. The firm's subsidary include Bafna Lifestyles Remedies Limited.

Show more
Loading
BAFNAPH
BSE Sensex 30
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Bansilal Mahaveer Chand Bafna
Chief Executive Officer
No Bio Available
Mr. Melagiri Sridhar
Chief Financial Officer
No Bio Available
Mr. Vinayak Dinesh Dendukuri
Whole-Time Director of Quality
No Bio Available
Ms. Shanmugam Hemalatha
Executive Chairman
No Bio Available
Mr. A. Mohanachandran
Company Secretary & Compliance Officer
No Bio Available

Contacts

Address
TAMIL NADU
Chennai
Bafna Towers, 299, Thambu Chetty street
Contacts
+914442677555
www.bafnapharma.com
sparklesyt

See Also

Summary
BAFNAPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
BAFNAPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BAFNAPH stock valuation using valuation multiples.
Wall Street Estimates
BAFNAPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BAFNAPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 319,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.